Clinical outcome to clozapine treatment in chronic psychiatric inpatients

Clinical outcome to clozapine treatment in chronic psychiatric inpatients 1. 1. A review of the medical records in a state psychiatric hospital was conducted to evaluate the clinical efficacy of the atypical antipsychotic, clozapine. 2. 2. Using the Brief Psychiatric Rating Scale (BPRS), four groups of schizophrenic inpatients ( n = 59) were operationally defined: Nonresponders (< 20% decrease from pre-drug baseline); Short-term Pharmacological Responders (20% decline, but not sustained); Long-term Pharmacological Responders (maintained a 20% decline) and Clinical Responders (maintained a 20% decline and achieved a BPRS < 36; the criterion of Kane et al. 1988). 3. 3. There were 7 NRs, 13 STPRs, 21 LTPRs and 18 CRs. 4. 4. The STPR, LTPR and CR groups improved significantly within the first month of treatment and reached a 20% decrease in BPRS by 3 months. CRs required 5 months to attain a BPRS < 36. These criteria were reached at the same average doses (about 300–400 mg/day). 5. 5. The proportion of CRs (30%) in this retrospective, naturalistic study, is remarkably close to the results of the definitive study by Kane et al. 1988. These results are also consistent with many of the controlled research studies of clozapine in hospitalized, treatment refractory psychiatric patients. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Progress in Neuro-Psychopharmacology & Biological Psychiatry Elsevier

Clinical outcome to clozapine treatment in chronic psychiatric inpatients

Loading next page...
 
/lp/elsevier/clinical-outcome-to-clozapine-treatment-in-chronic-psychiatric-2puUFfqpan
Publisher
Elsevier
Copyright
Copyright © 1999 Elsevier Ltd
ISSN
0278-5846
eISSN
1878-4216
D.O.I.
10.1016/S0278-5846(98)00087-6
Publisher site
See Article on Publisher Site

Abstract

1. 1. A review of the medical records in a state psychiatric hospital was conducted to evaluate the clinical efficacy of the atypical antipsychotic, clozapine. 2. 2. Using the Brief Psychiatric Rating Scale (BPRS), four groups of schizophrenic inpatients ( n = 59) were operationally defined: Nonresponders (< 20% decrease from pre-drug baseline); Short-term Pharmacological Responders (20% decline, but not sustained); Long-term Pharmacological Responders (maintained a 20% decline) and Clinical Responders (maintained a 20% decline and achieved a BPRS < 36; the criterion of Kane et al. 1988). 3. 3. There were 7 NRs, 13 STPRs, 21 LTPRs and 18 CRs. 4. 4. The STPR, LTPR and CR groups improved significantly within the first month of treatment and reached a 20% decrease in BPRS by 3 months. CRs required 5 months to attain a BPRS < 36. These criteria were reached at the same average doses (about 300–400 mg/day). 5. 5. The proportion of CRs (30%) in this retrospective, naturalistic study, is remarkably close to the results of the definitive study by Kane et al. 1988. These results are also consistent with many of the controlled research studies of clozapine in hospitalized, treatment refractory psychiatric patients.

Journal

Progress in Neuro-Psychopharmacology & Biological PsychiatryElsevier

Published: Jan 1, 1999

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off